Brady Family Wealth LLC Sells 144 Shares of Aflac Incorporated (NYSE:AFL)

Brady Family Wealth LLC reduced its stake in Aflac Incorporated (NYSE:AFL) by 0.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 21,525 shares of the financial services provider’s stock after selling 144 shares during the period. Brady Family Wealth LLC’s holdings in Aflac were worth $2,406,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Strategic Financial Concepts LLC raised its stake in shares of Aflac by 7,001.0% during the second quarter. Strategic Financial Concepts LLC now owns 667,706 shares of the financial services provider’s stock valued at $596,000 after acquiring an additional 658,303 shares during the last quarter. Truist Financial Corp grew its position in shares of Aflac by 26.6% in the 2nd quarter. Truist Financial Corp now owns 1,929,662 shares of the financial services provider’s stock worth $172,338,000 after buying an additional 405,847 shares during the last quarter. Swedbank AB bought a new stake in shares of Aflac in the 1st quarter worth approximately $27,588,000. Dimensional Fund Advisors LP increased its stake in shares of Aflac by 6.3% during the second quarter. Dimensional Fund Advisors LP now owns 4,807,079 shares of the financial services provider’s stock valued at $429,319,000 after buying an additional 285,576 shares during the period. Finally, Envestnet Asset Management Inc. raised its holdings in shares of Aflac by 27.6% during the second quarter. Envestnet Asset Management Inc. now owns 1,243,189 shares of the financial services provider’s stock valued at $111,029,000 after acquiring an additional 268,694 shares in the last quarter. Institutional investors own 67.44% of the company’s stock.

Aflac Stock Down 0.1 %

Shares of AFL opened at $113.99 on Wednesday. The firm has a market cap of $64.77 billion, a P/E ratio of 12.58, a PEG ratio of 2.62 and a beta of 0.95. The stock’s 50 day moving average is $108.55 and its two-hundred day moving average is $95.36. The company has a current ratio of 0.10, a quick ratio of 0.10 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 12 month low of $75.07 and a 12 month high of $115.50.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.83 EPS for the quarter, topping the consensus estimate of $1.60 by $0.23. Aflac had a return on equity of 16.22% and a net margin of 28.35%. The business had revenue of $5.14 billion for the quarter, compared to analyst estimates of $4.10 billion. During the same quarter in the previous year, the firm earned $1.58 EPS. The company’s quarterly revenue was down .7% compared to the same quarter last year. Analysts predict that Aflac Incorporated will post 6.76 earnings per share for the current fiscal year.

Aflac Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, September 2nd. Stockholders of record on Wednesday, August 21st were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.75%. The ex-dividend date of this dividend was Wednesday, August 21st. Aflac’s payout ratio is 22.08%.

Insider Activity

In related news, Director Thomas J. Kenny sold 2,000 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total transaction of $197,880.00. Following the transaction, the director now owns 18,158 shares of the company’s stock, valued at $1,796,552.52. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Company insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on AFL. Wells Fargo & Company lifted their price objective on Aflac from $90.00 to $106.00 and gave the company an “equal weight” rating in a research report on Thursday, October 10th. JPMorgan Chase & Co. increased their price target on shares of Aflac from $85.00 to $90.00 and gave the company a “neutral” rating in a report on Thursday, October 3rd. UBS Group lifted their price objective on Aflac from $84.00 to $109.00 and gave the stock a “neutral” rating in a report on Wednesday, August 14th. Morgan Stanley increased their price objective on shares of Aflac from $91.00 to $98.00 and gave the company an “equal weight” rating in a research report on Monday, August 19th. Finally, Piper Sandler raised their target price on Aflac from $114.00 to $122.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $97.53.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.